New chemical tools to probe cell wall biosynthesis in bacteria

Current Opinion in Microbiology

Volumn 27, Issue , 2015, Pages 69-77

  Gale, Robert T ^a   Brown, Eric D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PEPTIDOGLYCAN; TEICHOIC ACID; MOLECULAR PROBE;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BIOGENESIS; BIOSYNTHESIS; DRUG DEVELOPMENT; ENZYME SPECIFICITY; MOLECULAR DYNAMICS; MOLECULAR PROBE; MOLECULAR WEIGHT; NONHUMAN; PENICILLIN RESISTANCE; PROTEIN ASSEMBLY; PROTEIN POLYMERIZATION; REVIEW; BACTERIUM; CELL WALL; DRUG EFFECTS; METABOLISM; PROCEDURES; ULTRASTRUCTURE;

BACTERIA (MICROORGANISMS);

ANTI-BACTERIAL AGENTS; BACTERIA; CELL WALL; DRUG DISCOVERY; DRUG RESISTANCE, BACTERIAL; MOLECULAR PROBES; PEPTIDOGLYCAN; TEICHOIC ACIDS;

EID: 84939494381     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2015.07.013     Document Type: Review

References (52)

1. Silver L.L. Viable screening targets related to the bacterial cell wall. Ann N Y Acad Sci 2013, 1277:29-53.
2. Bugg T.D.H., Braddick D., Dowson C.G., Roper D.I. Bacterial cell wall assembly: still an attractive antibacterial target. Trends Biotechnol 2011, 29:167-173.
3. Schneider T., Sahl H.-G. An oldie but a goodie-cell wall biosynthesis as antibiotic target pathway. Int J Med Microbiol 2010, 300:161-169.
4. Egan A.J.F., Vollmer W. The physiology of bacterial cell division. Ann N Y Acad Sci 2013, 1277:8-28.
5. van Heijenoort Y., Gómez M., Derrien M., Ayala J., van Heijenoort J. Membrane intermediates in the peptidoglycan metabolism of Escherichia coli: possible roles of PBP 1b and PBP 3. J Bacteriol 1992, 174:3549-3557.
6. Ye X.-Y., Lo M.-C., Brunner L., Walker D., Kahne D., Walker S. Better substrates for bacterial transglycosylases. J Am Chem Soc 2001, 123:3155-3156.
7. VanNieuwenhze M.S., Mauldin S.C., Zia-Ebrahimi M., Aikins J.A., Blaszczak L.C. The total synthesis of Lipid I. J Am Chem Soc 2001, 123:6983-6988.
8. VanNieuwenhze M.S., Mauldin S.C., Zia-Ebrahimi M., Winger B.E., Hornback W.J., Saha S.L., Aikins J.A., Blaszczak L.C. The first total synthesis of Lipid II: the final monomeric intermediate in bacterial cell wall biosynthesis. J Am Chem Soc 2002, 124:3656-3660.
9. Schwartz B., Markwalder J.A., Wang Y. Lipid II: total synthesis of the bacterial cell wall precursor and utilization as a substrate for glycosyltransfer and transpeptidation by penicillin binding protein (PBP) 1b of Escherichia coli. J Am Chem Soc 2001, 123:11638-11643.
10. Breukink E., van Heusden H.E., Vollmerhaus P.J., Swiezewska E., Brunner L., Walker S., Heck A.J.R., de Kruijff B. Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes. J Biol Chem 2003, 278:19898-19903.
11. Schneider T., Senn M.M., Berger-Bächi B., Tossi A., Sahl H.-G., Wiedemann I. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol Microbiol 2004, 53:675-685.
12. Braddick D., Sandhu S., Roper D.I., Chappell M.J., Bugg T.D.H. Observation of the time-course for peptidoglycan lipid intermediate II polymerization by Staphylococcus aureus monofunctional transglycosylase. Microbiology 2014, 160:1628-1636.
13. Baodong Ling B.B.-B. Increased overall antibiotic susceptibility in Staphylococcus aureus femAB null mutants. Antimicrob Agents Chemother 1998, 42:936.
14. Munch D., Engels I., Muller A., Reder-Christ K., Falkenstein-Paul H., Bierbaum G., Grein F., Bendas G., Sahl H.G., Schneider T. Structural variations of the cell wall precursor Lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin. Antimicrob Agents Chemother 2015, 59:772-781.
15. Ling L.L., Schneider T., Peoples A.J., Spoering A.L., Engels I., Conlon B.P., Mueller A., Schäberle T.F., Hughes D.E., Epstein S., et al. A new antibiotic kills pathogens without detectable resistance. Nature 2015, 517:455-459.
16. Qiao Y., Lebar M.D., Schirner K., Schaefer K., Tsukamoto H., Kahne D., Walker S. Detection of lipid-linked peptidoglycan precursors by exploiting an unexpected transpeptidase reaction. J Am Chem Soc 2014, 136:14678-14681.
17. Lebar M.D., Lupoli T.J., Tsukamoto H., May J.M., Walker S., Kahne D. Forming cross-linked peptidoglycan from synthetic Gram-negative Lipid II. J Am Chem Soc 2013, 135:4632-4635.
18. Lebar M.D., May J.M., Meeske A.J., Leiman S.A., Lupoli T.J., Tsukamoto H., Losick R., Rudner D.Z., Walker S., Kahne D. Reconstitution of peptidoglycan cross-linking leads to improved fluorescent probes of cell wall synthesis. J Am Chem Soc 2014, 136:10874-10877.
19. Zapun A., Philippe J., Abrahams K.A., Signor L., Roper D.I., Breukink E., Vernet T. In vitro reconstitution of peptidoglycan assembly from the Gram-positive pathogen Streptococcus pneumoniae. ACS Chem Biol 2013, 8:2688-2696.
20. Hsu S.-T.D., Breukink E., Bierbaum G., Sahl H.-G., de Kruijff B., Kaptein R., van Nuland N.A.J., Bonvin A.M.J.J. NMR study of mersacidin and Lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity. J Biol Chem 2003, 278:13110-13117.
21. Münch D., Müller A., Schneider T., Kohl B., Wenzel M., Bandow J.E., Maffioli S., Sosio M., Donadio S., Wimmer R., et al. The lantibiotic NAI-107 binds to bactoprenol-bound cell wall precursors and impairs membrane functions. J Biol Chem 2014, 289:12063-12076.
22. Huang L.-Y., Huang S.-H., Chang Y.-C., Cheng W.-C., Cheng T-JR, Wong C.H. Enzymatic synthesis of Lipid II and analogues. Angew Chem Int Ed Engl 2014, 53:8060-8065.
23. Mohammadi T., van Dam V., Sijbrandi R., Vernet T., Zapun A., Bouhss A., Diepeveen-de Bruin M., Nguyen-Distèche M., de Kruijff B., Breukink E. Identification of FtsW as a transporter of lipid-linked cell wall precursors across the membrane. EMBO J 2011, 30:1425-1432.
24. Mohammadi T., Sijbrandi R., Lutters M., Verheul J., Martin N.I., Blaauwen den T., de Kruijff B., Breukink E. Specificity of the transport of Lipid II by FtsW in Escherichia coli. J Biol Chem 2014, 289:14707-14718.
25. Sham L.-T., Butler E.K., Lebar M.D., Kahne D., Bernhardt T.G., Ruiz N. MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis. Science 2014, 345:220-222.
26. Huang S.-H., Wu W.-S., Huang L.-Y., Huang W.-F., Fu W.-C., Chen P.-T., Fang J.-M., Cheng W.-C., Cheng T-JR, Wong C.H. New continuous fluorometric assay for bacterial transglycosylase using Förster resonance energy transfer. J Am Chem Soc 2013, 135:17078-17089.
27. Kuru E., Hughes H.V., Brown P.J., Hall E., Tekkam S., Cava F., de Pedro M.A., Brun Y.V., VanNieuwenhze M.S. In situ probing of newly synthesized peptidoglycan in live bacteria with fluorescent d-amino acids. Angew Chem Int Ed Engl 2012, 51:12519-12523.
28. Kuru E., Tekkam S., Hall E., Brun Y.V., Van Nieuwenhze M.S. Synthesis of fluorescent d-amino acids and their use for probing peptidoglycan synthesis and bacterial growth in situ. Nat Protoc 2014, 10:33-52.
29. Siegrist M.S., Whiteside S., Jewett J.C., Aditham A., Cava F., Bertozzi C.R. d-Amino acid chemical reporters reveal peptidoglycan dynamics of an intracellular pathogen. ACS Chem Biol 2013, 8:500-505.
30. Liechti G.W., Kuru E., Hall E., Kalinda A., Brun Y.V., VanNieuwenhze M., Maurelli A.T. A new metabolic cell-wall labelling method reveals peptidoglycan in Chlamydia trachomatis. Nature 2013, 506:507-510.
31. D'Elia M.A., Millar K.E., Beveridge T.J., Brown E.D. Wall teichoic acid polymers are dispensable for cell viability in Bacillus subtilis. J Bacteriol 2006, 188:8313-8316.
32. Botella E., Devine S.K., Hubner S., Salzberg L.I., Gale R.T., Brown E.D, Link H., Sauer U., Codée J.D., Noone D., et al. PhoR autokinase activity is controlled by an intermediate in wall teichoic acid metabolism that is sensed by the intracellular PAS domain during the PhoPR-mediated phosphate limitation response of Bacillus subtilis. Mol Microbiol 2014, 94:1242-1259.
33. Atilano M.L., Pereira P.M., Yates J., Reed P., Veiga H., Pinho M.G., Filipe S.R. Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus. Proc Natl Acad Sci U S A 2010, 107:18991-18996.
34. Xu H., Wang L., Huang J., Zhang Y., Ma F., Wang J., Xu W., Zhang X., Yin Y., Wu K. Pneumococcal wall teichoic acid is required for the pathogenesis of Streptococcus pneumoniae in murine models. J Microbiol 2015, 53:147-154.
35. Weidenmaier C., Peschel A., Xiong Y.-Q., Kristian S.A., Dietz K., Yeaman M.R., Bayer A.S. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis 2005, 191:1771-1777.
36. Weidenmaier C., Kokai-Kun J.F., Kristian S.A., Chanturiya T., Kalbacher H., Gross M., Nicholson G., Neumeister B., Mond J.J., Peschel A. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 2004, 10:243-245.
37. Farha M.A., Leung A., Sewell E.W., D'Elia M.A., Allison S.E., Ejim L., Pereira P.M., Pinho M.G., Wright G.D., Brown E.D. Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactams. ACS Chem Biol 2013, 8:226-233.
38. Wang H., Gill C.J., Lee S.H., Mann P., Zuck P., Meredith T.C., Murgolo N., She X., Kales S., Liang L., et al. Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents. Chem Biol 2013, 20:272-284.
39. Sewell E.W., Brown E.D. Taking aim at wall teichoic acid synthesis: new biology and new leads for antibiotics. J Antibiot 2014, 67:43-51.
40. Pasquina L.W., Santa Maria J.P., Walker S. Teichoic acid biosynthesis as an antibiotic target. Curr Opin Microbiol 2013, 16:531-537.
41. Czarny T.L., Perri A.L., French S., Brown E.D. Discovery of novel cell wall-active compounds using PywaC, a sensitive reporter of cell wall stress, in the model Gram-positive bacterium Bacillus subtilis. Antimicrob Agents Chemother 2014, 58:3261-3269.
42. Zhang Y.-H., Ginsberg C., Yuan Y., Walker S. Acceptor substrate selectivity and kinetic mechanism of Bacillus subtilis TagA. Biochemistry 2006, 45:10895-10904.
43. Ginsberg C., Zhang Y.-H., Yuan Y., Walker S. In vitro reconstitution of two essential steps in wall teichoic acid biosynthesis. ACS Chem Biol 2006, 1:25-28.
44. Pereira M.P., Schertzer J.W., D'Elia M.A., Koteva K.P., Hughes D.W., Wright G.D., Brown E.D. The wall teichoic acid polymerase TagF efficiently synthesizes poly(glycerol phosphate) on the TagB product Lipid III. ChemBioChem 2008, 9:1385-1390.
45. Brown S., Zhang Y.-H., Walker S. A revised pathway proposed for Staphylococcus aureus wall teichoic acid biosynthesis based on in vitro reconstitution of the intracellular steps. Chem Biol 2008, 15:12-21.
46. Sewell E.W.C., Pereira M.P., Brown E.D. The wall teichoic acid polymerase TagF is non-processive in vitro and amenable to study using steady state kinetic analysis. J Biol Chem 2009, 284:21132-21138.
47. Allison S.E., D'Elia M.A., Arar S., Monteiro M.A., Brown E.D. Studies of the genetics, function, and kinetic mechanism of TagE, the wall teichoic acid glycosyltransferase in Bacillus subtilis 168. J Biol Chem 2011, 286:23708-23716.
48. Brown S., Xia G., Luhachack L.G., Campbell J., Meredith T.C., Chen C., Winstel V., Gekeler C., Irazoqui J.E., Peschel A., et al. Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc Natl Acad Sci U S A 2012, 109:18909-18914.
49. Müller A., Ulm H., Reder-Christ K., Sahl H.-G., Schneider T. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors. Microb Drug Resist 2012, 18:261-270.
50. Wright G. Antibiotics: an irresistible newcomer. Nature 2015, 517:442-444.
51. Gale R.T., Sewell E.W., Garrett T.A., Brown E.D. Reconstituting poly(glycerol phosphate) wall teichoic acid biosynthesis in vitro using authentic substrates. Chem Sci 2014, 5:3823-3830.
52. Kawai Y., Marles-Wright J., Cleverley R.M., Emmins R., Ishikawa S., Kuwano M., Heinz N., Bui N.K., Hoyland C.N., Ogasawara N., et al. A widespread family of bacterial cell wall assembly proteins. EMBO J 2011, 30:4931-4941.